Randomized Double-Blind, 12-Week Study Of Pregabalin In Subjects With Restless Legs Syndrome.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 28 Jun 2010
At a glance
- Drugs Pregabalin (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Jun 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 May 2010 Planned end date changed from 1 Apr 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 06 Mar 2010 Planned initiation date changed from 1 Feb 2010 to 1 May 2010 as reported by ClinicalTrials.gov.